AnaptysBio, Inc. (ANAB) Social Stream
ANAPTYSBIO INC (ANAB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ANAPTYSBIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $50 | $19 | $35 | $23.02 | 52.04% |
| 2022-03-07 | 6 | $50 | $25 | $36 | $23.02 | 56.39% |
| 2022-03-15 | 5 | $50 | $25 | $36.166 | $23.02 | 57.11% |
| 2022-03-18 | 7 | $50 | $24 | $36 | $23.02 | 56.39% |
| 2022-05-05 | 6 | $50 | $24 | $34 | $23.02 | 47.7% |
| 2022-05-12 | 6 | $50 | $23 | $33.8 | $23.02 | 46.83% |
| 2022-08-09 | 5 | $50 | $23 | $32.25 | $23.02 | 40.1% |
| 2022-08-11 | 5 | $50 | $23 | $32.5 | $23.02 | 41.18% |
| 2022-09-01 | 6 | $50 | $23 | $31.2 | $23.02 | 35.53% |
| 2022-09-13 | 6 | $30 | $21 | $25.2 | $23.02 | 9.47% |
| 2022-09-19 | 7 | $35 | $21 | $26.833 | $23.02 | 16.56% |
| 2022-11-01 | 7 | $44 | $21 | $29.285 | $23.02 | 27.22% |
| 2022-11-09 | 7 | $44 | $23 | $32 | $23.02 | 39.01% |
| 2022-11-21 | 7 | $44 | $23 | $33.142 | $23.02 | 43.97% |
| 2023-01-06 | 6 | $44 | $23 | $31.2 | $23.02 | 35.53% |
| 2023-03-02 | 6 | $44 | $28 | $32.2 | $23.02 | 39.88% |
| 2023-05-11 | 6 | $44 | $28 | $32 | $23.02 | 39.01% |
| 2023-05-12 | 7 | $45 | $22 | $31 | $23.02 | 34.67% |
| 2023-05-22 | 6 | $45 | $28 | $33 | $23.02 | 43.35% |
| 2023-08-08 | 5 | $45 | $26 | $32.25 | $23.02 | 40.1% |
| 2023-08-09 | 5 | $45 | $20 | $30.25 | $23.02 | 31.41% |
| 2023-10-26 | 5 | $45 | $18 | $28.25 | $23.02 | 22.72% |
| 2023-11-02 | 6 | $45 | $18 | $26.8 | $23.02 | 16.42% |
| 2023-11-15 | 6 | $45 | $20 | $27.2 | $23.02 | 18.16% |
The Trend in the Analyst Price Target
ANAB's average price target has moved up $2 over the prior 14 months.
Over the past 37 weeks, ANAB's average upside potential has been 61.48%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-12 | 6 | 44 | 28 | 32.00 | 21.13 | 51.44% |
| 2023-05-11 | 6 | 44 | 28 | 32.00 | 20.76 | 54.14% |
| 2023-05-22 | 6 | 45 | 28 | 33.00 | 19.98 | 65.17% |
| 2023-08-08 | 5 | 45 | 26 | 32.25 | 18.95 | 70.18% |
| 2023-11-06 | 6 | 45 | 20 | 27.20 | 16.67 | 63.17% |
ANAB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 2 | 0 | 4 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 40 months, ANAB's average broker recommendation rating improved by 0.67.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ANAPTYSBIO INC's variance in analysts' estimates is lower than -2350.25% of all US stocks.
- ANAB has a greater number of analysts covering the stock than 900.39% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ANAPTYSBIO INC's upside potential (average analyst target price relative to current price) is higher than 1001.38% of them.
- In the context of Pharmaceutical Products stocks, ANAPTYSBIO INC's average analyst price target is greater than 1801.49% of them.
In the Pharmaceutical Products industry, PTGX, AXSM, and BPMC are the three stocks most similar to ANAPTYSBIO INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ANAB a Buy, Hold or Sell? See the POWR Ratings now!